279 Does Postoperative Gabapentinoid Prescription Reduce Chronic Opiate Use Following Long-Segment Lumbar Instrumentation?

View at publisher Summarise with VIRAT
Authors: Janesh Karnati, Andrew E. Wu, Xu Tao, Gabriel L. Jelkin, Aydin Kaghazchi, Ahmed Ashraf, Sruthi Ranganathan, Shameel Abid, Leina M. Lunasco, Sachin Shankar, Mikayla Wallace, Joseph S. Cheng
+1 more Owoicho Adogwa
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: As physicians have become more aware of the growing opiate epidemic and high rates of postoperative opioid prescription, multimodal pain management using gabapentinoids has emerged as a promising strategy in opiate use reduction. However, their efficacy in reducing postoperative opiate consumption remain uncertain, particularly in the context of spine surgery. METHODS: The TriNetX Research Network was queried to identify patients who underwent multi-level lumbar instrumentation. The study cohort was stratified into two groups: one group consisted of patients who were prescribed a gabapentinoid within 30 days following index surgery, while the comparison group included patients who did not receive a gabapentinoid within the same timeframe. Propensity score matching was performed, thereby controlling for potential confounders. Presence of prescription for select postoperative opioids was assessed between 3-6 months, 6-12 months, and 12-24 months following index surgery using RxNorm codes. RESULTS: After propensity score matching, each cohort comprised 2,463 equally matched patients. Post-matching analysis revealed that patients who were prescribed gabapentinoids within the first 30 days following surgery had significantly lower odds of being prescribed non-codeine-based and strong opiates from 3 to 6 months (OR = 0.723 and OR = 0.813, respectively), 6 months to 1 year (OR = 0.762 and OR = 0.834, respectively), and 1 year to 2 years (OR = 0.750 and OR = 0.762, respectively) following surgery compared to those who did not receive initial postoperative gabapentinoid prescription. Additionally, those who received an initial gabapentinoid prescription had significantly higher odds of being prescribed weak opiates from 3 to 6 months and 6 months to 1 year (OR = 1.289 and OR = 1.341, respectively) following index surgery; however, this was not statistically significant from 1 to 2 years (OR = 1.151, 95% CI [0.978, 1.354]). CONCLUSIONS: This analysis suggests that patients who received a gabapentinoid prescription within 30 days following long-segment posterior lumbar instrumentation had significantly lower odds of chronic postoperative non-codeine-based and strong opioid use. However, initial gabapentinoid prescription was also associated with increased odds of weak opioid use during the early postoperative period, though this trend was not observed beyond one year.

Fields of Study & Subjects

Opioid Use Disorder Treatment Anesthesia and Pain Management Pain Management and Opioid Use

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
69–69
Publication date
26 March 2026
Language
EN